Pages that link to "Q46247570"

The following pages link to Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study (Q46247570):

Displaying 25 items.

• Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer (Q27009306) (← links)
• Menopause, hormone therapy and diabetes (Q30239769) (← links)
• Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy (Q33649441) (← links)
• Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer (Q34152848) (← links)
• Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers (Q34435034) (← links)
• Bilateral oophorectomy, body mass index, and mortality in U.S. women aged 40 years and older (Q36108138) (← links)
• Impact of risk-reducing salpingo-oophorectomy in premenopausal women (Q36372962) (← links)
• Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule (Q36490048) (← links)
• Insulin resistance in women's health: why it matters and how to identify it (Q36664199) (← links)
• Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers. (Q37512375) (← links)
• Adherence to Mediterranean Diet and Metabolic Syndrome in BRCA Mutation Carriers (Q38662947) (← links)
• Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy. (Q40462939) (← links)
• Weight gain after oophorectomy among women with a BRCA1 or BRCA2 mutation (Q40641271) (← links)
• Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. (Q40732955) (← links)
• Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis (Q44696764) (← links)
• Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study (Q45891161) (← links)
• Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study. (Q47958061) (← links)
• Metabolic syndrome in menopause and associated factors: a meta-analysis (Q50075574) (← links)
• Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors. (Q51764443) (← links)
• Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy (Q56243477) (← links)
• Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations (Q57480089) (← links)
• Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy (Q57902945) (← links)
• Long noncoding RNA LINC01234 promotes serine hydroxymethyltransferase 2 expression and proliferation by competitively binding miR-642a-5p in colon cancer (Q61796562) (← links)
• Surveillance of survivors: Follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers (Q84004623) (← links)
• ERRα activates SHMT2 transcription to enhance the resistance of breast cancer to lapatinib via modulating the mitochondrial metabolic adaption (Q92370310) (← links)